Tumor necrosis factor-␣ (TNF) inhibits fat cell differentiation and may also mediate insulin resistance in adipocytes. Both TNF receptors are expressed in adipose tissue, but it is unknown how both receptors are involved in these biological functions. We therefore studied the effect of receptor-specific TNF muteins on adipose differentiation and insulin-stimulated glucose transport of in vitro differentiated human adipocytes in primary culture. Adipocyte precursor cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific TNF R32W-S86T showed a marked decrease in the percentage of differentiating cells in response to adipogenic factors as well as a reduction in peroxisome proliferator-activated receptor-␥2 (PPAR␥2) messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH) activity, but increased endogenous TNF mRNA expression. When cells were incubated with the p80-TNFR-specific TNF D143N-A145R , adipogenesis and PPAR␥2 mRNA expression were stimulated, GPDH activity was unchanged, and TNF mRNA was completely suppressed. Insulin-stimulated 2-deoxy-D-glucose transport was inhibited by both muteins. The p60-TNFR-mediated inhibition increased continuously during 6 h of treatment and was associated with a down-regulation of glucose transporter-4 (GLUT4) mRNA and GLUT4 protein, whereas the p80-TNFR-specific mutein caused a transient increase in GLUT4 mRNA, but did not alter GLUT4 protein expression after a 24-h incubation. We conclude that p60-TNFR mediates the antiadipogenic effect as well as the down-regulation of GLUT4 by TNF, thereby leading to long-term inhibition of insulin-stimulated glucose transport. In contrast, activation of the p80-TNFR induces an adipogenic effect and transiently up-regulates GLUT4 expression. Here, the acute inhibition of insulin-stimulated glucose transport may be induced by interference with the insulin signaling pathway. (Endocrinology 141: [2582][2583][2584][2585][2586][2587][2588] 2000) 
tivity was unchanged, and TNF mRNA was completely suppressed. Insulin-stimulated 2-deoxy-D-glucose transport was inhibited by both muteins. The p60-TNFR-mediated inhibition increased continuously during 6 h of treatment and was associated with a down-regulation of glucose transporter-4 (GLUT4) mRNA and GLUT4 protein, whereas the p80-TNFR-specific mutein caused a transient increase in GLUT4 mRNA, but did not alter GLUT4 protein expression after a 24-h incubation. We conclude that p60-TNFR mediates the antiadipogenic effect as well as the down-regulation of GLUT4 by TNF, thereby leading to long-term inhibition of insulin-stimulated glucose transport. In contrast, activation of the p80-TNFR induces an adipogenic effect and transiently up-regulates GLUT4 expression. Here, the acute inhibition of insulin-stimulated glucose transport may be induced by interference with the insulin signaling pathway. T UMOR necrosis factor-␣ (TNF) is a multifunctional cytokine that exerts a variety of biological effects (for review, see Ref. 1) . In addition to its immunological action, high levels of circulating TNF seem to be responsible for the development of cachexia in patients with cancer or infectious diseases (for review, see Ref. 2) . Based upon this observation, subsequent studies suggested an important role of TNF for adipose tissue growth and metabolism (3) (4) (5) (6) . TNF was also found to be expressed in adipose tissue of rodents and humans. As adipose tissue TNF messenger RNA (mRNA) amounts are increased in obese subjects, it was assumed that this locally produced TNF could function as an endogenous inhibitor of adipose tissue growth and may be involved in the development of obesity-linked insulin resistance (7) (8) (9) (10) .
This hypothesis is substantiated by many in vitro studies in different preadipose and adipose cell models. Under most experimental conditions TNF prevents adipose differentiation in rodent as well as human adipose tissue (3, 4) caused by a variety of mechanisms. TNF was reported to impair the uptake and storage of fatty acids by decreasing the expression and activity of lipoprotein lipase (5, 6) . Moreover, TNF suppresses glucose uptake and subsequently prevents de novo lipid synthesis (11) . This inhibition of lipid storage and, in addition, activation of lipolysis (5) results in lipid depletion of mature adipocytes and finally leads to the reversion of the adipocyte phenotype (3, 4) .
Interestingly, TNF inhibits insulin-stimulated glucose uptake by different mechanisms. In rat Fao hepatoma cells, components of the insulin signaling pathway were reported to be down-regulated within 1 h of TNF exposure (12) . Comparable results were described after short-term TNF treatment of human adipocytes (13) and also after chronic 5-day incubation of 3T3 adipocytes with TNF (14) . In addition, long-term TNF treatment down-regulates mRNA expression of the insulin-responsive glucose transporter-4 (GLUT4) (11) . Based upon these findings, TNF appears to inhibit insulinstimulated glucose transport by suppressing both the production and translocation of the GLUT4 protein.
Although some TNF effects on adipose tissue metabolism are now well characterized, little is currently known about the mechanisms preceding signal transduction. TNF mediates its pleiotropic effects by activation of two different receptors, a 60-kDa TNF receptor subtype (p60-TNFR) and an 80-kDa TNF receptor subtype (p80-TNFR) (15) . Both receptors are expressed in stromal preadipose and adipose cells obtained from human adipose tissue (10) . Little is known about the relative contributions of both TNF receptors to the role of TNF in adipose differentiation and fat cell function. Studies in 3T3-L1 adipocytes using receptor-specific agonistic antibodies suggested that TNF exerts its inhibitory effect on insulin signaling through stimulation of the p55-TNFR (16) . Therefore, it was the aim of this study to define the receptor specificity of TNF action on the differentiation and metabolism of human adipocytes in primary culture by using recently developed TNF receptor-selective TNF muteins. The specific binding of these TNF muteins to recombinant TNF receptors and their specific functional activity were extensively studied in established human cell models of TNF action (17) .
Materials and Methods Subjects
Adipose tissue samples were obtained from the mammary adipose tissue of young or middle-aged women undergoing elective surgical mammary reduction. All subjects were healthy and of normal weight or only moderately overweight with a body mass index below 27 kg/m 2 . All women were free of disorders of carbohydrate and lipid metabolism as assessed by history, clinical examination, and laboratory tests. Informed consent was obtained before surgical intervention.
Cell preparation and culture
The isolation of human adipocyte precursor cells was performed as previously described (18 
Determination of GPDH activity
Cells were harvested in 50 mm Tris-HCl, 1 mm EDTA, and 1 mm ␤-mercaptoethanol (pH 7.4). GPDH activity was determined in sonicated cell extracts according to an established procedure (19) . The protein content of the extracts was measured using a modification of the method of Lowry et al. (20) after protein precipitation with 6% trichloroacetic acid.
mRNA analysis
Total RNA was extracted with Trizol reagent (Life Technologies, Inc.) according to the instructions of the manufacturer. One microgram of the purified RNA was used for random primed complementary DNA (cDNA) synthesis as previously described (21) . Four percent of the RT volume was used for one PCR reaction, which also contained 0. The primer sets were: for TNF-␣, 5Ј-AAG ACC CCT CCC AGA TAG ATG-3Ј and 5Ј-GAG TGA CAA GCC TGT AGC CCA-3Ј; for peroxisome proliferator-activated receptor-␥2 (PPAR␥2), 5Ј-CTC CTA TTG ACC CAG AAA GCG A-3Ј and 5Ј-GTG GAG ATG CAG GCT CCA CTT-3Ј; for GLUT4: 5Ј-GAG GAA GGA GGA AAT CAT GCC-3Ј and 5Ј-CTG CGC GTC CAG CTC TTC TAA-3Ј; and for Sp1, 5Ј-GTT CAG AGC ATC AGA CCC CTC-3Ј and 5Ј-GAG AGT GGC TCA CAG CCT GTC-3Ј. PCR running conditions were 20-sec denaturation (94 C), 20-sec annealing (57 C), and 20-sec reaction for 30 cycles. The quantification of the PCR products was performed by phosphorimaging after separating the radiolabeled PCR products on a denaturing (8.3 m urea) 5% PAGE (22) . A cDNA fragment of the transcription factor Sp1 was coamplified in each assay as an internal standard. Sp1 expression is known to be stable in human preadipocytes and adipocytes as reported recently (21) . The specificity of the PCR products was tested by Southern hybridization or nested primer analysis. Sequential numbers of cycles were run to ensure that amplification of both fragments was within the exponential range of the PCR. 
Glucose transport assay
2-Deoxy-d-glucose uptake was determined as a functional parameter of the glucose transport system as previously described (11) . Seventytwo hours before the assay, insulin and glucose concentrations were reduced to 20 pm and 5 mm, respectively. wt-TNF or recombinant TNF (1 nm) was added 6, 4, and 2 h before glucose uptake was started, and cells were incubated either with or without 100 nm human insulin for 15 min before 1 Ci/dish 3 H-labeled 2-deoxy-d-glucose (4.5 m) was added. After 20 min at 37 C, glucose uptake was terminated on ice, cells were washed with PBS, and lysis was performed for 20 min in PBS containing 0.1% SDS. The amount of incorporated radioactivity was evaluated in a liquid scintillation counter (Beckman Coulter, Inc., Munich, Germany). Values were corrected for the unspecific uptake as previously described (11) .
Western blotting of GLUT4 protein
For Western blotting of GLUT4 crude membrane fractions were prepared from in vitro differentiated human fat cells cultured in 100-mm dishes (3-4 ϫ 10 6 cells) as described recently (11) . Protein samples (15-25 g) were subjected to SDS-PAGE and transferred to polyvinylidene fluoride filters (Immobilon-P, Millipore Corp., Bedford, MA) in a semidry blotting apparatus. The blots were incubated with a 1:100 dilution of a polyclonal antibody raised against GLUT4 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), washed several times, incubated with a second antibody antirabbit IgG conjugated with horseradish peroxidase, and detected with a chemiluminescence substrate (Lumi Light Plus, Roche, Mannheim, Germany).
Statistics
Results are presented as a mean percentage of the control value Ϯ se for five or more determinations or as a percentage of the control value Ϯ sd for less than five determinations. Controls were defined as 100%. Statistically significant differences were tested using Student's t test for paired data. P Յ 0.05 was considered statistically significant.
Results

TNF muteins and adipose differentiation
When stromal cells isolated from human sc adipose tissue were cultured under serum-free conditions in the presence of insulin, cortisol, and T 3 , an average of 40 -60% of the inoculated cells developed the adipocyte phenotype within 15-18 days. As shown in a previous study (4) , an initial 72-h incubation with 1 nm wt-TNF caused a marked reduction of adipose differentiation (percentage of differentiated cells: control, 38 Ϯ 9%; wt-TNF, 6 Ϯ 4%; P Ͻ 0.01).
Replacement of 1 nm wt-TNF by 1 nm p60-TNFR-specific TNF mutein (TNF R32W-S86T ) led to a similar degree of inhibition of adipose differentiation (percentage of differentiated cells, 5 Ϯ 3%). However, when cells were treated with 1 nm p80-TNFR-specific TNF D143N-A145R , a 1.5-to 2-fold increase in the number of differentiated cells was observed (percentage of differentiated cells, 58 Ϯ 18%; P ϭ NS vs. controls; Fig. 1 ). Concomitant administration of both TNF muteins at concentrations of 0.01, 0.1, and 1 nm each, respectively, resulted in a dose-dependent inhibition of adipogenesis, comparable to the effects of the same concentrations of wt-TNF alone (data not shown), indicating that stimulation of the p60-TNFR overrides the stimulatory effect of the p80-TNFR mutein.
To further elucidate the receptor specificity of TNF on adipogenesis, we measured the activity of the marker enzyme GPDH after 15 days of adipose differentiation in culture. In accordance with the morphological appearance, GPDH activity was significantly decreased after an initial 72-h treatment with either wt-TNF or TNF R32W-S86T at concentrations of 0.1 and 1.0 nm, but was not significantly influenced by a 72-h exposure to a 0.1-or 1-nm p80-TNFRspecific stimulus (Fig. 2, upper graph) . When newly differentiated fat cells were chronically exposed to either 0.1 or 1 nm wt-TNF or TNF R32W-S86T from days 15-25, a dosedependent depletion of cellular lipid droplets was observed, which was accompanied by a down-regulation of GPDH activity. After exposure of newly differentiated adipocytes to TNF D143N-A145R , neither a loss of cellular lipids nor a change in GPDH activity was detectable (Fig. 2, lower graph) .
As a second early emerging differentiation marker we determined mRNA levels of the nuclear receptor PPAR␥2 using a semiquantitative RT-PCR technique. Compared with control cultures, cells treated with 1 nm TNF or TNF R32W-S86T for the initial 3 days showed markedly decreased PPAR␥2 FIG. 2 . Effects of TNF and receptor-specific TNF muteins on GPDH activity in in vitro differentiated human fat cells. Stromal cells were exposed to 1 nM wt-TNF or TNF-muteins for the initial 3 days, and GPDH activity was determined after 15 days in adipogenic culture medium (upper graph). Newly differentiated fat cells after 15 days in adipogenic culture medium were chronically treated with either wt-TNF or TNF muteins, and GPDH activity was measured after an additional 10 days in culture (lower graph). Results are expressed as a percentage Ϯ SE of the control value, which was defined as 100% [equivalent to 1329 Ϯ 178 mU/mg protein (upper graph) and 1094 Ϯ 394 mU/mg protein (lower graph); n ϭ 6]. *, P Ͻ 0.01. mRNA amounts when cells were harvested after 15 days of culture. In contrast, in cultures initially exposed to 1 nm p80-TNFR-specific mutein, PPAR␥2-mRNA levels were elevated more than 2-fold on day 15 (Fig. 3A) .
Under the same experimental conditions, we determined the endogenous expression of TNF mRNA in cultured human preadipocytes and detected a 2-fold increase in TNF mRNA levels after a 3-day incubation with either 1 nm wt-TNF or 1 nm TNF R32W-S86T . In contrast, TNF mRNA was reduced to an undetectable level when cells were treated for the initial 3 days with 1 nm TNF D143N-A145R (Fig. 3B) .
Effect of TNF muteins on insulin-stimulated glucose transport and GLUT4 mRNA expression in newly differentiated human adipocytes
After 18 days in the adipogenic medium, when cells have acquired the adipocyte phenotype, glucose transport was measured. Cultures exposed to 1 nm wt-TNF showed a significantly reduced rate of insulin-stimulated glucose uptake after a 2-h incubation. This inhibitory effect was slightly greater after 4-and 6-h incubation periods, respectively. Basal glucose uptake was not significantly altered during exposure for up to 6 h (Fig. 4, upper graph) . A comparison of TNFR-specific effects clearly showed that stimulation of either p60-TNFR or the p80-TNFR was sufficient to significantly reduce insulin-stimulated glucose uptake within 2 h of incubation. Although the p60-TNFR-mediated inhibition of insulin-stimulated glucose transport increased with exposure time, the p80-TNFR-mediated effect was already maximal after a 2-h period, but then rapidly returned to baseline levels within 6 h. As observed for wt-TNF, neither mutein significantly influenced basal transport under these conditions (Fig. 4, middle and lower graphs) .
To further characterize the TNF effects on glucose transport, newly developed adipocytes were incubated under identical conditions for the semiquantitative detection of GLUT4 mRNA. The amounts of GLUT4 mRNA were significantly decreased after treatment with 1 nm wt-TNF, independent of the exposure time (Fig. 5A) . In contrast, stimulation of p60-TNFR by TNFR R32W-S86T resulted in a similar, if not more pronounced, down-regulation of GLUT4 mRNA, which became diminished when cells were exposed to TNF R32W-S86T for 24 h (Fig. 5B) . Surprisingly, GLUT4 expression was slightly, but significantly, stimulated when cultures were incubated with 1 nm TNF D143N-A145R for not longer than 4 h (Fig. 5C) . Measurement of GLUT4 protein by immunoblotting revealed that a 24-h exposure of human adipocytes to 1 nm TNF R32W-S86T resulted in a reduction of GLUT4 protein level by approximately 50%, whereas exposure of cells to 1 nm TNF D143N-A145R did not significantly alter the amount of GLUT4 protein (Fig. 6 ).
Discussion
The results of this study clearly indicate that the antiadipogenic effect exerted by TNF is exclusively mediated by p60-TNFR. After selective stimulation of this receptor subtype by a TNF mutein, the morphological development of the adipocyte phenotype was prevented in accordance with the suppression of the adipogenic markers PPAR␥2 mRNA and GPDH activity. Furthermore, the p60-TNFR-specific ligand was found to induce a dose-dependent reversion of the fat cell phenotype in fully developed adipocytes, indicated by an almost complete loss of intracellular lipid droplets, as recently reported for soluble wt-TNF (4). These findings very closely resemble the results obtained after treatment with wt-TNF and therefore suggest that the p60-TNFR is mediating these metabolic effects of soluble TNF in human adi- FIG. 3 . Effect of 1 nM wt-TNF or 1 nM receptor-specific TNF muteins on PPAR␥2 mRNA (A) and TNF-mRNA (B) during differentiation of human adipocyte precursor cells in primary culture. Cells were exposed to wt-TNF or muteins for the 3 initial days under adipogenic culture conditions. After random primed cDNA synthesis, mRNA was detected by PCR. The relative amounts of the specific PCR fragments were related to the respective amounts of the coamplified Sp1 product. Results are expressed as a percentage Ϯ SD of the control value, which was defined as 100% (n ϭ 4). *, P Ͻ 0.01.
pose tissue as reported for most other organ systems (1). This conclusion is also supported by the results of a recent study in TNFR-deficient preadipocyte cell lines established from knockout ob/ob mice lacking p55-TNFR, p75-TNFR, or both. In this study the TNF-related inhibition of the adipose differentiation program was predominantly attributed to p55-TNFR, which is the rodent homolog of human p60-TNFR (23) .
Surprisingly, the p80-TNFR-directed ligand caused the opposite effect, i.e. a stimulation of adipogenesis. This was obvious from the morphological appearance of the cultures. The number of differentiating cells as well as the amount of PPAR␥2 mRNA were nearly doubled. In addition, the mRNA of the insulin-responsive GLUT4, which is expressed in a differentiation-dependent fashion (24) , was slightly up-regulated after 2-4 h of stimulation with 1 nm TNF D143N-A145R . These findings are also in agreement with the results of the above-mentioned study in TNFR knockout mice, where a lack of the p75-TNFR was associated with a significant decrease in body weight compared with that of wild-type animals and mice lacking both receptors (25) . However, when both selective TNFR agonists were combined, the effect of TNF D143N-A145R was clearly overridden by the action of the p60-TNFR-specific TNF R32W-S86T in our model of human adipocytes.
Although the observed changes in morphology as well as in PPAR␥2 mRNA expression were substantial, GPDH activity remained at the level of the control cells after exposure to the p80-TNFR-specific mutein. GPDH activity, however, is a limiting factor for de novo lipid synthesis. The observation that this key enzyme was not influenced, in contrast to the obviously increased lipid accumulation of the cells, is presently unexplained. However, it is noteworthy that adipocyte GPDH is a homodimeric enzyme, which may be allosterically regulated in its catalytic activity (26) . As GPDH activity was measured in cell extracts under distinct conditions, the results obtained may reflect only the amount of active enzyme molecules, not their former velocity in intact cells.
Recent studies in the 3T3-L1 preadipocyte cell-line using p55-TNFR agonistic antibodies or ceramide, a lipid messenger of p55-TNFR signaling, have demonstrated that the murine analog of the p60-TNFR is responsible for the induction of disturbances in insulin receptor signaling (16) . Indeed, our results clearly show a marked and rapid reduction of insulinstimulated glucose transport upon selective stimulation of the p60-TNFR. This effect could be due to an impairment of insulin signaling at the level of insulin receptor substrate-1 tyrosine phosphorylation and insulin receptor substrate-1-associated phosphatidylinositol 3-kinase activity as recently demonstrated by our group in isolated human adipocytes (13) . However, our present experiments also suggest a rapid suppression of GLUT4 mRNA, which may contribute to the chronic suppression of insulin-stimulated glucose transport. It is noteworthy that measurement of GLUT4 protein after a 24-h exposure of adipocytes to either TNF R32W-S86T or TNF D143N-A145R showed that only stimulation of p60-TNFR induced a reduction in GLUT4 protein, whereas the stimulatory effect of the selective p80-TNFR agonist on GLUT4 mRNA expression was only temporary and did not significantly affect the amount of GLUT4 protein. Thus, it may be speculated that the inhibitory effect of the selective p80-TNFR agonist may be exerted at the level of insulin signaling and/or GLUT4 translocation. This is also in agreement with the above-mentioned study in which neutralization of the p80-TNFR ameliorated the inhibitory action of TNF on insulin-stimulated glucose transport in human adipocytes (13) .
A comparison of these receptor-specific responses with the effects of wt-TNF clearly indicates that the effects of soluble wt-TNF are primarily mediated by a p60-TNFR-specific signal. This is particularly the case for the observed long-term effect on adipogenesis. However, concerning glucose transport the rapid wt-TNF effect could also involve the p80-TNFR. It may be concluded from these experiments that the p80-TNFR may represent a signal transducer of short-term effects, and the p60-TNF may be a mediator of both shortand long-term effects. This assumption would be in accordance with a clinical study of TNFR expression in adipose tissue. In this study, the p60-TNFR was stably expressed, whereas the p80-TNFR was highly regulated (10) .
Another aspect addressed by our experiments is the regulation of endogenous TNF expression. Up-regulation of TNF expression by a stimulation of the p60-TNFR would extend the TNF signal in an auto-/paracrine manner. In contrast, selective activation of the p80-TNFR led to a downregulation of TNF expression. The stimulation of endogenous TNF mRNA expression by wt TNF and the selective p60-TNFR agonist was not unexpected, as similar results were reported for other cell types (1) . It is also known that the TNF promotor contains a TNF-responsive element (27) . Thereby, our experiments suggest that the autostimulation of TNF expression, at least in adipocytes, is mediated by the p60-TNFR. The suppression of endogenous TNF mRNA by TNF D143N-A145R is a new finding and could at least partly explain the stimulation of adipogenesis, as other adipogenic substances, such as phosphodiesterase inhibitors, have been found to act as inhibitors of TNF expression in several cell species (1, 28) , including human preadipocytes and adipocytes (29) .
Our results provoke the question of how these opposite signals operate in vivo. It is known that soluble TNF primarily stimulates the p60-TNFR, whereas the membrane-bound TNF precursor is able to activate both receptors independently (30) . Moreover, like TNF itself, both TNF receptors were shown to be cleaved by proteolytic activities (31) (32) (33) . Such mechanisms and probably the regulation of ligand and receptor expression would be suitable to explain the transduction of a TNF signal by both or exclusively one of the two TNF receptor subtypes. Based upon such arguments, a molecular switch at the receptor level from adipogenic to antiadipogenic TNF action and vice versa may be conceivable. To extend this speculation, a TNF signal in adipose tissue generated by fat cells would normally be antiadipogenic and regulated by a critical fat cell size to prevent further expansion. This prevention would be achieved by the induction of insulin resistance due to interference with insulin signaling and suppression of GLUT4 production. In contrast, in the case of abundant supply with triglycerides and in the presence of high insulin concentrations the TNF signal could be switched to a more adipogenic, p80-TNFR-mediated action to allow storage of excess energy. This would induce both insulin resistance in enlarged fat cells and recruitment of adipocyte precursor cells for differentiation.
In conclusion, our results indicate that TNF is not only acting as an antiadipogenic factor for fat cells and their precursors, but also seems to be able to promote fat cell differentiation under certain conditions via a specific p80-TNFRmediated effect. This pattern of opposite signaling includes the regulation of GLUT4 expression, where p60-TNFRmediated signals induce a long-term down-regulation, while p80-TNFR-mediated signals do not substantially affect GLUT4 expression. Both TNF receptors appear to mediate a suppression of insulin-stimulated glucose uptake and to be involved in insulin resistance. Further investigations are required to further elucidate the pathways by which both TNF receptors may specifically interfere with insulin signaling.
